Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women

Journal of Steroid Biochemistry and Molecular Biology

Volumn 99, Issue 4-5, 2006, Pages 182-188

  Labrie, Fernand ^a   Bélanger, Alain ^a   Bélanger, Patrick ^a   Bérubé, René ^a   Martel, Céline ^a   Cusan, Leonello ^a   Gomez, José ^a   Candas, Bernard ^a   Castiel, Isabelle ^b   Chaussade, Véronique ^b   Deloche, Claire ^b   Leclaire, Jacques ^b  

^a LAVAL UNIVERSITY   (Canada)

^b L ORÉAL RECHERCHE   (France)

Author keywords

Androgenic activity marker; Androsterone; Glucuronides; Intracrinology; Mass spectrometry; Testosterone

Indexed keywords

ANDROGEN GLUCURONIDE; ANDROSTENEDIOL DERIVATIVE; ANDROSTERONE DERIVATIVE; GLUCURONIDE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; AGED; ANDROGEN METABOLISM; ARTICLE; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NORMAL HUMAN; POSTMENOPAUSE; PREMENOPAUSE; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; ANDROGENS; BIOLOGICAL MARKERS; DEHYDROEPIANDROSTERONE; FEMALE; GLUCURONIDES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; TESTOSTERONE;

EID: 33646793000     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.02.004     Document Type: Article

References (25)

1. Labrie F., Luu-the V., Labrie C., Bélanger A., Simard J., Lin S.-X., and Pelletier G. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of asndrogens and their precursor dehydroepiandrosterone. Endocr. Rev. 24 (2003) 152-182
2. Basson R. A new model of female sexual desire. Endocr. News 29 (2004) 22
3. Tchernof A., and Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk. A review of human studies. Eur. J. Endocr. 151 (2004) 1-14
4. Shifren J.L., Braunstein G.D., Simon J.A., Casson P.R., Buster J.E., Redmond G.P., Burki R.E., Ginsburg E.S., Rosen R.C., Leiblum S.R., Caramelli K.E., and Mazer N.A. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N. Engl. J. Med. 343 (2000) 682-688
5. Sherwin B.B., and Gelfand M.M. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom. Med. 49 (1987) 397-409
6. Cameron D.R., and Braunstein G.D. Androgen replacement therapy in women. Fertil. Steril. 82 (2004) 273-289
7. Garland C.F., Friedlander N.J., Barrett-Connor E., and Khaw K.T. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am. J. Epidemiol. 135 (1992) 1220-1230
8. Leiblum S., Bachmann G., Kemmann E., Colburn D., and Swartzman L. Vaginal atrophy in the postmenopausal women. The importance of sexual activity and hormones. JAMA 249 (1983) 2195-2198
9. Lipworth L., Adami H.O., Trichopoulos D., Carlstrom K., and Matzoros C. Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer. Epidemiology 7 (1996) 96-100
10. Davis S.R., McCloud P., Strauss B.J., and Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 21 (1995) 227-236
11. Fels E. Treatment of breast cancer with testosterone propionate. A preliminary report. J. Clin. Endocrinol. 4 (1944) 121-125
12. Segaloff A., Gordon D., Horwitt B.N., Schlosser J.V., and Murison P.J. Hormonal therapy in cancer of the breast. 1. The effect of testosterone propionate therapy on clinical course and hormonal excretion. Cancer 4 (1951) 319-323
13. Labrie F., Poulin R., Simard J., Luu-The V., Labrie C., and Bélanger A. Androgens, DHEA and breast cancer. In: Gelfand T. (Ed). Androgens and Reproductive Aging (2006), Taylor and Francis, Oxsfordshire UK 113-135
14. Labrie F., and Intracrinology. Mol. Cell. Endocrinol. 78 (1991) C113-C118
15. Labrie F., Belanger A., Cusan L., and Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J. Clin. Endocrinol. Metab. 82 (1997) 2403-2409
16. Labrie C., Bélanger A., and Labrie F. Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 123 (1988) 1412-1417
17. Dowsett M., and Folkerd E. Deficits in plasma oestradiol measurement in studies and management of breast cancer. Breast Cancer Res. 7 (2005) 1-4
18. McShane L.M., Dorgan J.F., Greenhut S., and Damato J.J. Reliability and validity of serum sex hormone measurements. Cancer Epidemiol. Biomarkers Prev. 5 (1996) 923-928
19. Rinaldi S., Dechaud H., Biessy C., Morin-Raverot V., Toniolo P., Zeleniuch-Jacquotte A., Akhmedkhanov A., Shore R.E., Secreto G., Ciampi A., Riboli E., and Kaaks R. Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 757-765
20. Dorgan J.F., Fears T.R., McMahon R.P., Aronson Friedman L., Patterson B.H., and Greenhut S.F. Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry. Steroids 67 (2002) 151-158
21. Poortman J., Thijssen J.H., von Landeghem A.A., Wiegerinck M.A., and Alsbach G.P. Subcellular distribution of androgens and oestrogens in target tissue. J. Steroid Biochem. 19 (1983) 939-945
22. Labrie F., Dupont A., and Bélanger A. Complete androgen blockade for the treatment of prostate cancer. In: de Vita V.T., Hellman S., and Rosenberg S.A. (Eds). Important Advances in Oncology (1985), J.B. Lippincott, Philadelphia 193-217
23. Bélanger B., Bélanger A., Labrie F., Dupont A., Cusan L., and Monfette G. Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men. J. Steroid Biochem. 32 (1989) 695-698
24. Bélanger A., Pelletier G., Labrie F., Barbier O., and Chouinard S. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol. Metab. 14 (2003) 473-479
25. Zwicker H., and Rittmaster R.S. Androsterone sulfate: physiology and clinical significance in hirsute women. J. Clin. Endocrinol. Metab. 76 (1993) 112-116